Researchers have identified a potential new biomarker for cognitive decline associated with Alzheimer's disease. The study reports fibrinogen, a blood clotting protein, causes a series of molecular events that may trigger the destruction of connections between neurons, resulting in cognitive decline.
A new study reports reduced levels of Rheb result in memory loss in animal models of dementia.
A new study reports on the role the protein TDP-43 plays in the development of Alzheimer's disease.
Reconstituting the amount of chondroitin 6-sulphate to perineuronal nets completely restored memory and brain plasticity in aging mice to a similar level as seen in younger animals, a new study reports. The findings could lead to new therapies to restore age-related memory loss in older humans.
Researchers have identified a possible new drug target that could help to restore memory loss and improve longevity in Alzheimer's disease.
Researchers report of accelerated cognitive decline in Alzheimer's disease patient who also exhibit signs of delirium.
A new study reports Hispanic people not only tend to develop symptoms of Alzheimer's earlier than other racial groups, they also show earlier manifestations of neuropsychiatric symptoms associated with the disease.
Researchers report a single dose of an immunotherapy treatment successfully reversed memory loss in a mouse model of Alzheimer's disease.
According to a new study, amyloid beta, a key component in Alzheimer's disease progression, can cause memory loss in healthy brains prior to the onset of dementia.